Clinical trial
A phase 2, interventional, single arm study describing platelet responses and itp remission rates in adult subjects with immune thrombocytopenia purpura receiving romiplostim
The primary objective is to describe the number of months with a subject platelet response over a 12 month treatment period.
| Category | Value |
|---|---|
| Study start date | 2010-08-26 |